 | • レポートコード：QYR9ST04479 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ヒトマイクロバイオームベース薬物及び診断の世界市場について調査・分析し、ヒトマイクロバイオームベース薬物及び診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（治療、診断）、用途別（臨床研究所、病院、外科センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のヒトマイクロバイオームベース薬物及び診断市場動向 ・主要企業別マーケットシェア ・ヒトマイクロバイオームベース薬物及び診断の種類別市場規模2014-2019 （治療、診断） ・ヒトマイクロバイオームベース薬物及び診断の用途別市場規模2014-2019 （臨床研究所、病院、外科センター、その他） ・ヒトマイクロバイオームベース薬物及び診断の北米市場：主要企業・種類別/用途別市場規模 ・ヒトマイクロバイオームベース薬物及び診断のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ヒトマイクロバイオームベース薬物及び診断の中国市場：主要企業・種類別/用途別市場規模 ・ヒトマイクロバイオームベース薬物及び診断の日本国内市場：主要企業・種類別/用途別市場規模 ・ヒトマイクロバイオームベース薬物及び診断の東南アジア市場：主要企業・種類別/用途別市場規模 ・ヒトマイクロバイオームベース薬物及び診断のインド市場：主要企業・種類別/用途別市場規模 ・ヒトマイクロバイオームベース薬物及び診断の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Second Genome、Enterome Bioscience、Yakult、DuPont、Vedanta BioSciences、Metabiomics Corporation、ViThera Pharmaceuticals、MicroBiome Therapeutics、Osel、Merck） ・ヒトマイクロバイオームベース薬物及び診断の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.Rising cases of chronic diseases such as diabetes, disorders at early stage and the ability of the drugs to diagnose them and increased awareness among people to maintain healthy lifestyle is driving the growth of this market.
In 2018, the global Human Microbiome Based Drugs and Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Human Microbiome Based Drugs and Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Microbiome Based Drugs and Diagnostics development in United States, Europe and China.
The key players covered in this study
Second Genome
Enterome Bioscience
Yakult
DuPont
Vedanta BioSciences
Metabiomics Corporation
ViThera Pharmaceuticals
MicroBiome Therapeutics
Osel
Merck
Market segment by Type, the product can be split into
Therapeutics
Diagnostics
Market segment by Application, split into
Clinical Research Institutes
Hospital
Surgical Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Human Microbiome Based Drugs and Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Human Microbiome Based Drugs and Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Human Microbiome Based Drugs and Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Therapeutics
1.4.3 Diagnostics
1.5 Market by Application
1.5.1 Global Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2025)
1.5.2 Clinical Research Institutes
1.5.3 Hospital
1.5.4 Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Human Microbiome Based Drugs and Diagnostics Market Size
2.2 Human Microbiome Based Drugs and Diagnostics Growth Trends by Regions
2.2.1 Human Microbiome Based Drugs and Diagnostics Market Size by Regions (2014-2025)
2.2.2 Human Microbiome Based Drugs and Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Human Microbiome Based Drugs and Diagnostics Market Size by Manufacturers
3.1.1 Global Human Microbiome Based Drugs and Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Human Microbiome Based Drugs and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Human Microbiome Based Drugs and Diagnostics Key Players Head office and Area Served
3.3 Key Players Human Microbiome Based Drugs and Diagnostics Product/Solution/Service
3.4 Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019)
4.2 Global Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019)
5 United States
5.1 United States Human Microbiome Based Drugs and Diagnostics Market Size (2014-2019)
5.2 Human Microbiome Based Drugs and Diagnostics Key Players in United States
5.3 United States Human Microbiome Based Drugs and Diagnostics Market Size by Type
5.4 United States Human Microbiome Based Drugs and Diagnostics Market Size by Application
6 Europe
6.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size (2014-2019)
6.2 Human Microbiome Based Drugs and Diagnostics Key Players in Europe
6.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type
6.4 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application
7 China
7.1 China Human Microbiome Based Drugs and Diagnostics Market Size (2014-2019)
7.2 Human Microbiome Based Drugs and Diagnostics Key Players in China
7.3 China Human Microbiome Based Drugs and Diagnostics Market Size by Type
7.4 China Human Microbiome Based Drugs and Diagnostics Market Size by Application
8 Japan
8.1 Japan Human Microbiome Based Drugs and Diagnostics Market Size (2014-2019)
8.2 Human Microbiome Based Drugs and Diagnostics Key Players in Japan
8.3 Japan Human Microbiome Based Drugs and Diagnostics Market Size by Type
8.4 Japan Human Microbiome Based Drugs and Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size (2014-2019)
9.2 Human Microbiome Based Drugs and Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size by Type
9.4 Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size by Application
10 India
10.1 India Human Microbiome Based Drugs and Diagnostics Market Size (2014-2019)
10.2 Human Microbiome Based Drugs and Diagnostics Key Players in India
10.3 India Human Microbiome Based Drugs and Diagnostics Market Size by Type
10.4 India Human Microbiome Based Drugs and Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Human Microbiome Based Drugs and Diagnostics Market Size (2014-2019)
11.2 Human Microbiome Based Drugs and Diagnostics Key Players in Central & South America
11.3 Central & South America Human Microbiome Based Drugs and Diagnostics Market Size by Type
11.4 Central & South America Human Microbiome Based Drugs and Diagnostics Market Size by Application
12 International Players Profiles
12.1 Second Genome
12.1.1 Second Genome Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.1.4 Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.1.5 Second Genome Recent Development
12.2 Enterome Bioscience
12.2.1 Enterome Bioscience Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.2.4 Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.2.5 Enterome Bioscience Recent Development
12.3 Yakult
12.3.1 Yakult Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.3.4 Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.3.5 Yakult Recent Development
12.4 DuPont
12.4.1 DuPont Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.4.4 DuPont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.4.5 DuPont Recent Development
12.5 Vedanta BioSciences
12.5.1 Vedanta BioSciences Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.5.4 Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.5.5 Vedanta BioSciences Recent Development
12.6 Metabiomics Corporation
12.6.1 Metabiomics Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.6.4 Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.6.5 Metabiomics Corporation Recent Development
12.7 ViThera Pharmaceuticals
12.7.1 ViThera Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.7.4 ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.7.5 ViThera Pharmaceuticals Recent Development
12.8 MicroBiome Therapeutics
12.8.1 MicroBiome Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.8.4 MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.8.5 MicroBiome Therapeutics Recent Development
12.9 Osel
12.9.1 Osel Company Details
12.9.2 Company Description and Business Overview
12.9.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.9.4 Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.9.5 Osel Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Human Microbiome Based Drugs and Diagnostics Introduction
12.10.4 Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
12.10.5 Merck Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Human Microbiome Based Drugs and Diagnostics Key Market Segments
Table Key Players Human Microbiome Based Drugs and Diagnostics Covered
Table Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size Market Share by Type 2014-2025
Figure Therapeutics Figures
Table Key Players of Therapeutics
Figure Diagnostics Figures
Table Key Players of Diagnostics
Table Global Human Microbiome Based Drugs and Diagnostics Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinical Research Institutes Case Studies
Figure Hospital Case Studies
Figure Surgical Centers Case Studies
Figure Others Case Studies
Figure Human Microbiome Based Drugs and Diagnostics Report Years Considered
Table Global Human Microbiome Based Drugs and Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Human Microbiome Based Drugs and Diagnostics Market Size by Regions 2014-2025 (Million US$)
Table Global Human Microbiome Based Drugs and Diagnostics Market Size by Regions 2014-2019 (Million US$)
Table Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions 2014-2019
Figure Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions 2014-2019
Figure Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions 2019
Table Market Top Trends
Table Global Human Microbiome Based Drugs and Diagnostics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Human Microbiome Based Drugs and Diagnostics Market Share by Manufacturers (2014-2019)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Share by Manufacturers in 2018
Table Global Human Microbiome Based Drugs and Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Human Microbiome Based Drugs and Diagnostics Product/Solution/Service
Table Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Type (2014-2019)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Application (2014-2019)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Application in 2018
Figure United States Human Microbiome Based Drugs and Diagnostics Market Size 2014-2019 (Million US$)
Table United States Key Players Human Microbiome Based Drugs and Diagnostics Revenue (2018-2019) (Million US$)
Table United States Key Players Human Microbiome Based Drugs and Diagnostics Market Share (2018-2019)
Table United States Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019) (Million US$)
Table United States Human Microbiome Based Drugs and Diagnostics Market Share by Type (2014-2019)
Table United States Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table United States Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2019)
Figure Europe Human Microbiome Based Drugs and Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Human Microbiome Based Drugs and Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Human Microbiome Based Drugs and Diagnostics Market Share (2018-2019)
Table Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Europe Human Microbiome Based Drugs and Diagnostics Market Share by Type (2014-2019)
Table Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Europe Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2019)
Figure China Human Microbiome Based Drugs and Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Human Microbiome Based Drugs and Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Human Microbiome Based Drugs and Diagnostics Market Share (2018-2019)
Table China Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-20189) (Million US$)
Table China Human Microbiome Based Drugs and Diagnostics Market Share by Type (2014-2019)
Table China Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table China Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2019)
Figure Japan Human Microbiome Based Drugs and Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Human Microbiome Based Drugs and Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Human Microbiome Based Drugs and Diagnostics Market Share (2018-2019)
Table Japan Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Japan Human Microbiome Based Drugs and Diagnostics Market Share by Type (2014-2019)
Table Japan Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Japan Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2019)
Figure Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Human Microbiome Based Drugs and Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Human Microbiome Based Drugs and Diagnostics Market Share (2018-2019)
Table Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Share by Type (2014-2019)
Table Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2019)
Figure India Human Microbiome Based Drugs and Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Human Microbiome Based Drugs and Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Human Microbiome Based Drugs and Diagnostics Market Share (2018-2019)
Table India Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019) (Million US$)
Table India Human Microbiome Based Drugs and Diagnostics Market Share by Type (2014-2019)
Table India Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table India Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2019)
Figure Central & South America Human Microbiome Based Drugs and Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Human Microbiome Based Drugs and Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Human Microbiome Based Drugs and Diagnostics Market Share (2018-2019)
Table Central & South America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Human Microbiome Based Drugs and Diagnostics Market Share by Type (2014-2019)
Table Central & South America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Human Microbiome Based Drugs and Diagnostics Market Share by Application (2014-2019)
Table Second Genome Company Details
Table Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019) (Million US$)
Figure Second Genome Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table Second Genome Recent Development
Table Enterome Bioscience Company Details
Table Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure Enterome Bioscience Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table Enterome Bioscience Recent Development
Table Yakult Company Details
Table Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure Yakult Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table Yakult Recent Development
Table DuPont Company Details
Table DuPont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure DuPont Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table DuPont Recent Development
Table Vedanta BioSciences Company Details
Table Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure Vedanta BioSciences Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table Vedanta BioSciences Recent Development
Table Metabiomics Corporation Company Details
Table Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure Metabiomics Corporation Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table Metabiomics Corporation Recent Development
Table ViThera Pharmaceuticals Company Details
Table ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure ViThera Pharmaceuticals Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table ViThera Pharmaceuticals Recent Development
Table MicroBiome Therapeutics Company Details
Table MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure MicroBiome Therapeutics Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table MicroBiome Therapeutics Recent Development
Table Osel Company Details
Table Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure Osel Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table Osel Recent Development
Table Merck Company Details
Table Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2014-2019)
Table Merck Recent Development
Table Global Human Microbiome Based Drugs and Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Regions in 2025
Figure United States Human Microbiome Based Drugs and Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Human Microbiome Based Drugs and Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Human Microbiome Based Drugs and Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Human Microbiome Based Drugs and Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Human Microbiome Based Drugs and Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Human Microbiome Based Drugs and Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Human Microbiome Based Drugs and Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size by Product (2019-2025)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size by Product in 2025
Table Global Human Microbiome Based Drugs and Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size by Application (2019-2025)
Figure Global Human Microbiome Based Drugs and Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ヒトマイクロバイオーム治療薬の世界市場：市場規模・現状・予測 Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…- ヒトパラインフルエンザウイルス診断の世界市場：市場規模・現状・予測 Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…
- ヒトパラインフルエンザウイルス診断の世界市場：市場規模・現状・予測 Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…
- 血液疾患用薬物および診断の世界市場：市場規模・現状・予測 Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood.Some blood disorders result in the increase of the number of cells in blood such as anemia, leukopenia while other cause the number of blood cells…
- 動物用治療及び診断の世界市場：市場規模・現状・予測 Diagnostic instruments aid in the determination of causative agents of diseases. The animal therapeutics and diagnostics market is growing at a steady pace due to the increase in pet ownership worldwide, especially in the developing countries. In 2018, the global Animal Therapeutics and Diagnostics …